FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Takayuki Maruyama

Research Profile

Chemicals & Drugs

Living Beings

Co-author Network

Publications

TOP 3
Hiroto Mitsui; Takashi Nakamura; Akio Nishiura; Takanobu Otsuka; Hikaru Sugihara; Tomoki Aoyama; Shinsei Fujimura; Moritoshi Furu; Kinya Ito; Yonghui Jin; Toshiya Kanaji; Takayuki Maruyama; Junya Toguchida
Prostaglandin E2 receptor type 2-selective agonist prevents the degeneration of articular cartilage in rabbit knees with traumatic instability.
Naoki Terada; Yosuke Shimizu; Tomomi Kamba; Takahiro Inoue; Atsushi Maeno; Takashi Kobayashi; Eijiro Nakamura; Toshiyuki Kamoto; Toshiya Kanaji; Takayuki Maruyama; Yoshiki Mikami; Yoshinobu Toda; Toshiyuki Matsuoka; Yasushi Okuno; Gozoh Tsujimoto; Shuh Narumiya; Osamu Ogawa
Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model.
Seiji Otsuka; Tomoki Aoyama; Moritoshi Furu; Koreaki Ito; Y Jin; A Nasu; Kenichi Fukiage; Yoshiki Kohno; Takayuki Maruyama; T Kanaji; A Nishiura; H Sugihara; S Fujimura; T Otsuka; Tetsuya Nakamura; Junya Toguchida
PGE2 signal via EP2 receptors evoked by a selective agonist enhances regeneration of injured articular cartilage.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Takayuki Maruyama (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Hiroto Mitsui; Takashi Nakamura; Akio Nishiura; Takanobu Otsuka; Hikaru Sugihara; Tomoki Aoyama; Shinsei Fujimura; Moritoshi Furu; Kinya Ito; Yonghui Jin; Toshiya Kanaji; Takayuki Maruyama; Junya Toguchida
Prostaglandin E2 receptor type 2-selective agonist prevents the degeneration of articular cartilage in rabbit knees with traumatic instability.
Arthritis research & therapy 2011;13(5):R146.
2010: Naoki Terada; Yosuke Shimizu; Tomomi Kamba; Takahiro Inoue; Atsushi Maeno; Takashi Kobayashi; Eijiro Nakamura; Toshiyuki Kamoto; Toshiya Kanaji; Takayuki Maruyama; Yoshiki Mikami; Yoshinobu Toda; Toshiyuki Matsuoka; Yasushi Okuno; Gozoh Tsujimoto; Shuh Narumiya; Osamu Ogawa
Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model.
Cancer research 2010;70(4):1606-15.
2009: Seiji Otsuka; Tomoki Aoyama; Moritoshi Furu; Koreaki Ito; Y Jin; A Nasu; Kenichi Fukiage; Yoshiki Kohno; Takayuki Maruyama; T Kanaji; A Nishiura; H Sugihara; S Fujimura; T Otsuka; Tetsuya Nakamura; Junya Toguchida
PGE2 signal via EP2 receptors evoked by a selective agonist enhances regeneration of injured articular cartilage.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2009;17(4):529-38.
2008: Yuhong Huang; Akira Marui; Hisashi Sakaguchi; Jiro Esaki; Yoshio Arai; Keiichi Hirose; Shyamal Chandra Bir; Hisanori Horiuchi; Takayuki Maruyama; Tadashi Ikeda; Yasuhiko Tabata; Masashi Komeda
Sustained release of prostaglandin E1 potentiates the impaired therapeutic angiogenesis by basic fibroblast growth factor in diabetic murine hindlimb ischemia.
Circulation journal : official journal of the Japanese Circulation Society 2008;72(10):1693-9.
2008: Mami Takahashi; Tsukasa Kitahashi; Rikako Ishigamori; Michihiro Mutoh; Masami Komiya; Hidetaka Sato; Yoshihisa Kamanaka; Masao Naka; Takayuki Maruyama; Takashi Sugimura; Keiji Wakabayashi
Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor.
Carcinogenesis 2008;29(8):1608-13.
2008: Eijiro Onishi; Shunsuke Fujibayashi; Mitsuru Takemoto; Masashi Neo; Takayuki Maruyama; Tadashi Kokubo; Takashi Nakamura
Enhancement of bone-bonding ability of bioactive titanium by prostaglandin E2 receptor selective agonist.
Biomaterials 2008;29(7):877-83.
2007: Hiroyuki Kohno; Mami Takahashi; Yumiko Yasui; Rikako Suzuki; Shingo Miyamoto; Yoshihisa Kamanaka; Masao Naka; Takayuki Maruyama; Keiji Wakabayashi; Takuji Tanaka
A specific inducible nitric oxide synthase inhibitor, ONO-1714 attenuates inflammation-related large bowel carcinogenesis in male Apc(Min/+) mice.
International journal of cancer. Journal international du cancer 2007;121(3):506-13.
2006: Akira Marui; Keiichi Hirose; Takayuki Maruyama; Yoshio Arai; Yuhong Huang; Kazuhiko Doi; Tadashi Ikeda; Masashi Komeda
Prostaglandin E2 EP4 receptor-selective agonist facilitates sternal healing after harvesting bilateral internal thoracic arteries in diabetic rats.
The Journal of thoracic and cardiovascular surgery 2006;131(3):587-93.
2006: Mami Takahashi; Michihiro Mutoh; Yutaka Shoji; Hidetaka Sato; Yoshihisa Kamanaka; Masao Naka; Takayuki Maruyama; Takashi Sugimura; Keiji Wakabayashi
Suppressive effect of an inducible nitric oxide inhibitor, ONO-1714, on AOM-induced rat colon carcinogenesis.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2006;14(2):130-6.
2005: Yutaka Shoji; Mami Takahashi; Nobuo Takasuka; Naoko Niho; Tomohiro Kitamura; Hidetaka Sato; Takayuki Maruyama; Yukihiko Sugimoto; Shuh Narumiya; Takashi Sugimura; Keiji Wakabayashi
Prostaglandin E receptor EP3 deficiency modifies tumor outcome in mouse two-stage skin carcinogenesis.
Carcinogenesis 2005;26(12):2116-22.
2005: Naoko Niho; Michihiro Mutoh; Tomohiro Kitamura; Mami Takahashi; Hidetaka Sato; Hiroshi Yamamoto; Takayuki Maruyama; Shuichi Ohuchida; Takashi Sugimura; Keiji Wakabayashi
Suppression of azoxymethane-induced colon cancer development in rats by a prostaglandin E receptor EP1-selective antagonist.
Cancer science 2005;96(5):260-4.
2005: Toshihiko Kawamori; Tomohiro Kitamura; Kouji Watanabe; Naoaki Uchiya; Takayuki Maruyama; Shuh Narumiya; Takashi Sugimura; Keiji Wakabayashi
Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.
Carcinogenesis 2005;26(2):353-7.
2004: Yutaka Shoji; Mami Takahashi; Tomohiro Kitamura; Kouji Watanabe; Toshihiko Kawamori; Takayuki Maruyama; Y Sugimoto; M Negishi; Shuh Narumiya; Takashi Sugimura; Keiji Wakabayashi
Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development.
Gut 2004;53(8):1151-8.
2003: Takayoshi Suganami; Kiyoshi Mori; Issei Tanaka; Masashi Mukoyama; Akira Sugawara; Hisashi Makino; Shigeo Muro; Kensei Yahata; Shuichi Ohuchida; Takayuki Maruyama; Shuh Narumiya; Kazuwa Nakao
Role of prostaglandin E receptor EP1 subtype in the development of renal injury in genetically hypertensive rats.
Hypertension 2003;42(6):1183-90.
2003: Mami Takahashi; Michihiro Mutoh; Yutaka Shoji; Yoshihisa Kamanaka; Masao Naka; Takayuki Maruyama; Takashi Sugimura; Keiji Wakabayashi
Transfection of K-rasAsp12 cDNA markedly elevates IL-1beta- and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells.
Oncogene 2003;22(48):7667-76.
2003: M Miyamoto; H Ito; S Mukai; Takuya Kobayashi; Hidetaka Yamamoto; Masahiko Kobayashi; Takayuki Maruyama; Haruhiko Akiyama; Tetsuya Nakamura
Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2003;11(9):644-52.
2003: Tomohiro Kitamura; Masaki Itoh; Tetsuo Noda; Kousuke Tani; Michiyoshi Kobayashi; Takayuki Maruyama; Kaoru Kobayashi; Shuichi Ohuchida; Takashi Sugimura; Keiji Wakabayashi
Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice.
Cancer science 2003;94(7):618-21.
2002: Hisashi Makino; Issei Tanaka; Masashi Mukoyama; Akira Sugawara; Kiyoshi Mori; Shigeo Muro; Takayoshi Suganami; Kensei Yahata; Rieko Ishibashi; Shuichi Ohuchida; Takayuki Maruyama; Shuh Narumiya; Kazuwa Nakao
Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist.
Journal of the American Society of Nephrology : JASN 2002;13(7):1757-65.
2002: Keiji Yoshida; Hiroji Oida; Takuya Kobayashi; Takayuki Maruyama; Masaharu Tanaka; Teruaki Katayama; Kojiro Yamaguchi; Eri Segi; Tadao Tsuboyama; Mutsumi Matsushita; Kosei Ito; Yoshiaki Ito; Yukihiko Sugimoto; Fumitaka Ushikubi; Shuichi Ohuchida; Kigen Kondo; Takashi Nakamura; Shuh Narumiya
Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(7):4580-5.
2002: Michihiro Mutoh; Kouji Watanabe; Tomohiro Kitamura; Yutaka Shoji; Mami Takahashi; Toshihiko Kawamori; Kousuke Tani; Michiyoshi Kobayashi; Takayuki Maruyama; Kaoru Kobayashi; Shuichi Ohuchida; Yukihiko Sugimoto; Shuh Narumiya; Takashi Sugimura; Keiji Wakabayashi
Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Cancer research 2002;62(1):28-32.
2001: Toshihiko Kawamori; Naoaki Uchiya; Seiichi Nakatsugi; Kouji Watanabe; Shuichi Ohuchida; Hiroshi Yamamoto; Takayuki Maruyama; Kigen Kondo; Takashi Sugimura; Keiji Wakabayashi
Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.
Carcinogenesis 2001;22(12):2001-4.
2001: Toshihiko Kawamori; Naoaki Uchiya; Tomohiro Kitamura; Shuichi Ohuchida; Hiroshi Yamamoto; Takayuki Maruyama; Takashi Sugimura; Keiji Wakabayashi
Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis.
Anticancer research 2001;21(6A):3865-9.
2001: S Shinomiya; Hiroaki Naraba; Akinori Ueno; I Utsunomiya; Takayuki Maruyama; Shuichi Ohuchida; Fumitaka Ushikubi; K Yuki; Shuh Narumiya; Yukihiko Sugimoto; Atsushi Ichikawa; Sachiko Oh-Ishi
Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists.
Biochemical pharmacology 2001;61(9):1153-60.
2001: Reiko Ikegami; Yukihiko Sugimoto; Eri Segi; Masato Katsuyama; Hisae Karahashi; Fumio Amano; Takayuki Maruyama; Hana Yamane; S Tsuchiya; Atsushi Ichikawa
The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(7):4689-96.
2000: Kouji Watanabe; Toshihiko Kawamori; Seiichi Nakatsugi; Toshihisa Ohta; Shuichi Ohuchida; Hiroshi Yamamoto; Takayuki Maruyama; Kigen Kondo; Shuh Narumiya; Takashi Sugimura; Keiji Wakabayashi
Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice.
Cancer letters 2000;156(1):57-61.
1999: Kouji Watanabe; Toshihiko Kawamori; Seiichi Nakatsugi; Toshihisa Ohta; Shuichi Ohuchida; Hiroshi Yamamoto; Takayuki Maruyama; Kigen Kondo; Fumitaka Ushikubi; Shuh Narumiya; Takashi Sugimura; Keiji Wakabayashi
Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.
Cancer research 1999;59(20):5093-6.